Literature DB >> 9338681

Mycobacterium chelonae keratitis after excimer laser photorefractive keratectomy.

R Brancato1, F Carones, E Venturi, A Cavallero, G Gesu.   

Abstract

This is the first report of a severe case of Mycobacterium chelonae keratitis; it occurred in a 26-year-old man after he had undergone excimer laser photorefractive keratectomy for the correction of severe myopia, once the epithelium was already healed. The diagnosis was made by culture results and acid-fast staining of corneal scrapings. Topical ciprofloxacin sodium, 0.3 mg/mL, plus amikacin sodium, 10 mg/mL, and oral clarithromycin sodium led to remission of the ulceration after 3 months of therapy. Subsequent topical corticosteroid therapy led to complete visual recovery during 1 year of follow-up. There may be an increased risk of severe keratitis during the first postoperative months in eyes that have already undergone photorefractive keratectomy, due to the presence of some microepithelial defects symptomatically negative and not easily detectable by slit-lamp examination.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9338681     DOI: 10.1001/archopht.1997.01100160486019

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  3 in total

Review 1.  [Diagnosis and treatment of mycobacterial keratitis following LASIK. Case report and review of the literature].

Authors:  M P Holzer; K D Solomon; H P Sandoval; G U Auffarth
Journal:  Ophthalmologe       Date:  2003-06-26       Impact factor: 1.059

Review 2.  Nontuberculous Mycobacterial Ocular Infections: A Systematic Review of the Literature.

Authors:  Wajiha J Kheir; Huda Sheheitli; Maamoun Abdul Fattah; Rola N Hamam
Journal:  Biomed Res Int       Date:  2015-05-27       Impact factor: 3.411

3.  Biofilms of Pathogenic Nontuberculous Mycobacteria Targeted by New Therapeutic Approaches.

Authors:  Thet Tun Aung; Joey Kuok Hoong Yam; Shuimu Lin; Shuhaida Mohamed Salleh; Michael Givskov; Shouping Liu; Nyein Chan Lwin; Liang Yang; Roger W Beuerman
Journal:  Antimicrob Agents Chemother       Date:  2015-10-12       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.